Telfast 120 mg 20 tablets

Tradename

Telfast

Telfast

Structure:

Each film-coated tablet contains 120mg of Fexofenadine hydrochloride.

Pharmacological group:

Antiallergic agent.

Pharmacological properties:

Telfast is an antihistamine drug that is an antagonist of histamine H-1 receptors. Does not sedate or otherwise affect the central nervous system. The antiallergic effect appears after 1 hour, after a maximum of 6 hours, continues to act for 24 hours.

Indications

Elimination of symptoms associated with seasonal allergic rhinitis (SAR) in adults and children over 12 years of age.

Mode of application:

Allergic rhinitis: 60mg (1/2 tablet) 2 times daily before meals.

Contraindications

hypersensitivity to fexofenadine, terfenadine or other components of the drug.

Side effects

Fexofenadine is generally well tolerated. The most common (1-10% of cases) reported headache, fatigue, dizziness or drowsiness, and nausea. In placebo-controlled studies with a frequency of less than 1%, weakness, insomnia, nervousness, sleep disturbance, tachycardia, palpitations, and diarrhea were noted. In rare cases (less than 0.1%), exanthema, urticaria, itching, Quincke’s edema, shortness of breath, shortness of breath, redness of the skin, anaphylactic reactions were observed.

Pregnancy Category B: There are no adequate and well controlled studies in pregnant women. Fexofenadine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Lactation: there are no data on the content of fexofenadine in breast milk when it is taken by breastfeeding women. Its penetration into breast milk was observed. The use of fexofenadine during breastfeeding is not recommended.

Storage

Store at room temperature out of reach of children.

Packaging:

in a cardboard box 2 blisters of 10 tablets and paper instructions.